Know Your Ports - Oncology Nursing News
WEBDec 21, 2017 · A port is typically placed on the right side of the patient’s chest and about 3 to 5 fingerbreadths below the clavicle. The insertion scar provides a useful landmark, because the port is usually located 0.5 to 1 inch below the surgical incision. Bringing a patient who has large amounts of breast tissue to a fully upright position, with the ...
Six Ways Nurses Can Advocate for Patients - Oncology Nursing …
WEBAug 30, 2018 · Six Ways Nurses Can Advocate for Patients. August 30, 2018. By Alene Nitzky, PhD, RN, OCN. Article. This is the first in a 3-part series about nurses as advocates within healthcare. Many nurses think of advocacy as the most important role we play in patient care. We need to remember that to best serve …
What Would You Do: Should Topical Anesthetics be Used to …
WEBNov 2, 2011 · Interventions to reduce the pain of port access should be considered, especially in patients who have a low pain threshold. Several types of anesthetics are available including topical, injectable, and nonpharmacological methods.
FDA Approves Aprepitant Injection for CINV - Oncology Nursing …
WEBMar 2, 2019 · The FDA has expanded the approval of aprepitant (Cinvanti) injectable emulsion to include a 2-minute intravenous (IV) use for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV).1. The decision is based on results of a two-part, phase I study that demonstrated bioequivalence and a similar safety profile for ...
Early Sepsis Recognition in Outpatient Settings: Challenges and …
WEBDec 14, 2016 · Frequently diagnosed in ICU settings, sepsis has usually progressed past its early stages once identified. Patients with cancer are at particularly high risk for developing sepsis, and severe septic infections are a factor in at least 8.5% of all cancer-related deaths. 1. Sepsis risk in the oncology setting is due to a variety of factors.
Breast Cancer Outcomes Can Be Predicted by Residual Cancer …
WEBDec 16, 2019 · Residual cancer burden (RCB) after neoadjuvant chemotherapy has been shown to be an accurate long-term predictor of disease recurrence and survival across all breast cancer subtypes, according to data from a large meta-analysis presented at the 2019 San Antonio Breast Cancer Symposium. 1. Several …
Why Choose Oncology as a Career Path? - Oncology Nursing News
WEBJan 23, 2019 · The oncology field is a one-stop shop of career prospects, from bedside nursing to coordination of care, education, research, leadership, and so much more. The opportunities for nurses in oncology are endless. With all of the great medical advances, technologies and opportunities available to be an expert in the field, my all-time favorite ...
A Rundown of New Infusion Therapies - Oncology Nursing News
WEBNov 12, 2020 · A Rundown of New Infusion Therapies. November 11, 2020. By Brielle Benyon. Article. A pharmacist provides an overview of new intravenous cancer therapies that were approved in 2020. In 2020, the FDA approved more than 50 new cancer treatment regimens, bringing 19 new drugs to the market. While the majority of …
ONS Publishes Guidelines for Personal Protective Equipment Use …
WEBMar 23, 2020 · The guidelines follow a most- to least-recommended use of gowns, masks, eye protection, gloves, and shoe covers. “Although ONS recognizes that these are not ideal, they are interim guidelines to support decision making and staff and patient safety in clinical care during the COVID-19 pandemic,” the statement said. Disposable poly-coated gown.
Management of Myelofibrosis and Adverse Events sees …
WEBSep 21, 2019 · Management and treatment of myelofibrosis has seen new progression with the approvals of 2 new JAK inhibitors, ruxolitinb (Jakafi) and fedratinib (Inrebic). Each of these drugs were major milestones in the myelofibrosis space, as ruxolitinb was the first and only drug to be approved for patients with steroid-refractory acute graft-versus-host disease (GVHD) and fedratinib was the first drug ...
Skip to content